<em>SOST</em>-targeted Antisense Oligonucleotide Mimics Splicing Mutation in Sclerosteosis to Enhance Osteogenesis <em>In Vitro</em> — ASN Events
  1. Schedule
  2. Concurrent Session: Symposium - Senescence, Rejuvenation, and Bone Ageing
  3. SOST-targeted Antisense Oligonucleotide Mimics Splicing Mutation in Sclerosteosis to Enhance Osteogenesis In Vitro

SOST-targeted Antisense Oligonucleotide Mimics Splicing Mutation in Sclerosteosis to Enhance Osteogenesis In Vitro (#46)

Jun Yuan 1 2 , Jun Lu 1 , Chi Pang Tai 1 , Ming-Hao Zheng 1 2
  1. Perron Institute, Perth, WESTERN AUSTRALIA, Australia
  2. School of Biological Sciences, The University of Western Australia, Perth, Western Australia, Australia
Publish consent withheld
  1. Brunkow ME, Gardner JC, Van Ness J, et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet. 2001;68(3):577-589.